Process development and manufacturing of ATMPs involve complex workflows with critical quality control checkpoints. Mycoplasma detection is a key safety assay, and global Pharmacopeias mandate strict guidelines to prevent contamination.
This webinar, “Safety assays for ATMPs: Improved mycoplasma detection for cell-based biotherapeutics,” explores safety strategies for cell-based biotherapeutics, focusing on mycoplasma detection using RT-dPCR. Unlike traditional culture or staining methods, RT-dPCR provides robust, reproducible results without standard curves, enabling faster, more sensitive detection.
Our speakers, Jens Björkman from CCRM Nordic and Andreas Hecker from QIAGEN, will share their combined expertise and present data showing how rRNA-based detection offers higher sensitivity than DNA-based methods, helping you manage contamination risks and meet regulatory expectations.
Watch the expert webinar session now.